Home › Encyclopedia › Anamorelin: Research Status, Trials, and Chemical Profile
Research / Unapproved

Anamorelin: Research Status, Trials, and Chemical Profile

Molecular formulaC31H42N6O3
Molecular weight546.7 g/mol
Registered trials11
PubChem CID9828911

What anamorelin is

Anamorelin is a synthetic compound identified by PubChem CID 9828911, with the molecular formula C31H42N6O3. It has no approved drug label from regulatory authorities, meaning there is no FDA-sanctioned indication, dosing guidance, or official prescribing information for it. It remains classified as a research compound rather than an approved medicine.

Trial footprint

Eleven trials involving anamorelin are registered in clinical trial databases. The available sample includes a completed Phase 2 dose range study in patients with non-small cell lung cancer (NCT00622193), a completed Phase 3 extension study examining anamorelin in non-small cell lung cancer cachexia (NCT01395914, known as ROMANA 3), and a completed Phase 1 study evaluating a ghrelin receptor agonist's effects on muscle and bone (NCT04021706). These records describe trial design and status only and do not establish that the compound is safe or effective for any use.

FAQ

Is anamorelin FDA approved?
No. There is no approved drug label for anamorelin, so it has no sanctioned medical indication. It remains an investigational compound studied in clinical trials.
What is anamorelin used for in research?
Clinical trials involving anamorelin have examined its effects in people with non-small cell lung cancer, including studies related to cancer cachexia, as well as effects on muscle and bone. These are research applications, not approved medical uses.
How many clinical trials have studied anamorelin?
Eleven trials involving anamorelin are registered, spanning Phase 1 through Phase 3 study designs. Several of these trials have reached completed status.
What is the chemical structure of anamorelin?
Anamorelin has the molecular formula C31H42N6O3 and a molecular weight of approximately 546.7. It is cataloged in PubChem under CID 9828911.
Are there known side effects of anamorelin?
No adverse event report data is available for this compound in the sources reviewed here. Because it lacks an approved label, there is no official safety profile to reference.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 9828911 ClinicalTrials.gov NCT00622193 ClinicalTrials.gov NCT01395914 ClinicalTrials.gov NCT04021706

Updated 2026-11-07